Table 4.
Group 1 (n=25) | Group 2 (n=25) | Group 3 (n=25) | Group 4 (n=25) | ||
---|---|---|---|---|---|
NLR | NLR | NLR | NLR | ||
≤3.68 | 3.69–6.03 | 6.04–10.28 | >10.28 | p | |
Ranson score, n (%) | |||||
<3 | 21 (84%) | 22 (88%) | 14 (56%) | 10 (40%) | <0.001 |
≥3 | 4 (16%) | 3 (12%) | 11 (44%) | 15 (60%) | |
CTSI score, n (%) | |||||
0–1 | 17 (68%) | 16 (64%) | 12 (48%) | 8 (32%) | 0.011 |
2–3 | 8 (32%) | 9 (36%) | 11 (44%) | 11 (44%) | |
4–6 | 0 (0%) | 0 (0%) | 2 (8%) | 6 (24%) | |
Surgical treatment, n (%) | 6 (24%) | 7 (28%) | 8 (32%) | 8 (32%) | 0.91 |
Local complications, n (%) | 0 (0%) | 0 (0%) | 4 (16%) | 6 (24%) | 0.007 |
Systemic complications, n (%) | 1 (4%) | 0 (0%) | 5 (20%) | 10 (40%) | <0.001 |
NLR: neutrophil-to-lymphocyte ratio; CTSI score: computed tomography severity index